Eucrates Biomedical Acquisition Corp.
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Eucrates Biomedical Acquisition Corp.'s balance sheet done over the years? Its assets were worth $12,485,358 last year, which is less than in the previous period. 32% of Eucrates Biomedical Acquisition Corp.’s total assets is currently financed by debt. Its liabilities reached the amount of $3,949,794, which means an decrease by -32% compared compared to last year.

Debt to Assets

Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR): Debt to assets
2020 105826906 3.72M 3.52%
2021 105106976 5.80M 5.52%
2022 12485358 3.94M 31.64%

EUCR Balance Sheet (2020 – 2022)

2022 2021 2020
Assets
Current assets:
Cash and cash equivalents
18.86K49.15K551.26K
Short term investments
12.35M00
Net receivables
000
Inventory
000
Other current assets
0215K0
Total current assets
132.19K264.15K1.02M
Non-current assets:
Property, Plant and Equipment
000
Goodwill
000
Intangible assets
000
Long term investments
000
Other non-current assets
12.35M104.84M104.80M
Total non-current assets
12.35M104.84M104.80M
Total assets
12.48M105.10M105.82M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
000
Short term debt
60.06K00
Total current liabilities
65.14K38.46K52.60K
Non-current liabilities:
Long term debt
000
Deferred tax
000
Other non-current liabilities
3.88M00
Total non-current liabilities
3.88M5.76M3.66M
Total liabilities
3.94M5.80M3.72M
Data sourceData sourceData source